Product Program year 2025 Source: CMS Open Payments

Fyarro

Biological Oncology

NDC 80803-153-50

Open in the dashboard

General payments

$52,175

6 payments

Research payments

$15,911,882

54 payments

Through program year 2025, $52,175 in general payments and $15,911,882 in research payments were reported against Fyarro (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $52,175 6
2025 Research $425,021 7
2024 Research $15,486,862 47

Breakdown

Who paid General payments · program year 2025
  1. Aadi Bioscience, Inc. $52,175 6 payments
Top recipients General payments · program year 2025
  1. Ralph Boccia Hematology & Oncology · Bethesda, MD $33,500 64% · 1 payment
  2. Brian Slomovitz Gynecologic Oncology · Fort Lauderdale, FL $7,650 15% · 2 payments
  3. Marilyn Bui Anatomic Pathology & Clinical Pathology · Tampa, FL $7,200 14% · 1 payment
  4. Robert Coleman Gynecologic Oncology · Houston, TX $3,825 7% · 2 payments

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $33,500 64% · 1 practitioner
  2. Gynecologic Oncology Obstetrics & Gynecology $11,475 22% · 2 practitioners
  3. Anatomic Pathology & Clinical Pathology Pathology $7,200 14% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Maryland $33,500 64% · 1 recipient
  2. Florida $14,850 28% · 2 recipients
  3. Texas $3,825 7% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

6 general · 54 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record